‘New Medicine Service’: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial
(2019)
Journal Article
Elliott, R. A., Boyd, M., Tanajewski, L., Barber, N., Gkountouras, G., Avery, A. J., …Chuter, A. (2019). ‘New Medicine Service’: supporting adherence in people starting a new medication for a long-term condition: 26-week follow-up of a pragmatic randomised controlled trial. BMJ Quality and Safety, 29(4), 286-295. https://doi.org/10.1136/bmjqs-2018-009177
All Outputs (4)
Identifying 'avoidable harm' in family practice: a RAND/UCLA Appropriateness Method consensus study (2019)
Journal Article
Carson-Stevens, A., Campbell, S., Bell, B., Cooper, A., Armstrong, S., Ashcroft, D., …Avery, A. (2019). Identifying 'avoidable harm' in family practice: a RAND/UCLA Appropriateness Method consensus study. BMC Family Practice, 20, https://doi.org/10.1186/s12875-019-0990-zBackground: Health care-related harm is an internationally recognized threat to public health. The United Kingdom’s national health services demonstrate that upwards of 90% of health care encounters can be delivered in ambulatory settings. Other coun... Read More about Identifying 'avoidable harm' in family practice: a RAND/UCLA Appropriateness Method consensus study.
Cultural intelligence of MPharm undergraduates (2019)
Journal Article
Alosaimi, N., Boyd, M., & Boardman, H. (2019). Cultural intelligence of MPharm undergraduates. International Journal of Pharmacy Practice, 27(S2), 27-28. doi:10.1111/ijpp.12533
Evaluation of the NHS England Phase 1 pilot: clinical pharmacists in general practice (2019)
Journal Article
BOYD, M., MANN, C., ANDERSON, C., AVERY, A., & WARING, J. (2019). Evaluation of the NHS England Phase 1 pilot: clinical pharmacists in general practice. International Journal of Pharmacy Practice, 27(S1), 4-5. https://doi.org/10.1111/ijpp.12508